1. Introduction {#sec1}
===============

Biological wastes, annually generated in important amounts from the agro-food industries, arouse a significant disposal burden when they are directly disposed to soil or landfill under poor management \[[@B1], [@B2]\]. In this line, the fruit processing industry, such as pomegranate, implies the raw material transformation to increase the added-value products \[[@B3]--[@B5]\]. Therefore, a huge amount of solid waste was generated. For example, for the pomegranate processing, approximately 500 g/kg of the pomegranate fruit composed from inedible portion, i.e., the peel and the remaining half has about 400 g/kg of juice and 100 g/kg of seeds \[[@B6]\]. Obviously, they still have notable content of polyphenols such as flavonoids, anthocyanins, hydroxybenzoic acids, hydroxycinnamic acids, and tannins \[[@B7]--[@B10]\] with beneficial effects on human health. Reported data demonstrate that phenolic compounds from pomegranate peel have diverse beneficial properties to health including anticancer activity \[[@B11]--[@B14]\], antidiarrheal activity \[[@B15]\], higher free radical scavenging activities \[[@B16]\], and strong antimicrobial activity \[[@B13], [@B17], [@B18]\]. In this context, several studies have reported the efficacy of pomegranate peel extracts (PPEs) to inhibit the growth of Gram-positive and Gram-negative bacteria, which are foodborne pathogens, spoilage bacteria, and human pathogens \[[@B19]--[@B23]\].

The extraction of pomegranate peels was primarily conducted for separating the phenolic compounds from the plant tissues. In this regard, the polarity of the solvent, extraction temperature, solid--solvent ratio, and particle size are influential parameters for extraction process \[[@B24]--[@B26]\]. Extraction of phenolic compounds from pomegranate peel has been reported \[[@B27]--[@B31]\], and in the most of these works, organic solvents such as methanol and acetone came up as suitable extraction solvents to reach good yields. However, environmentally benign and nontoxic food-grade organic solvents, such as ethanol, are recommended by the US Food and Drug Administration for extraction purposes \[[@B26], [@B32], [@B33]\].

As a result of the inability of conventional single variable optimization in the assessment of the individual and combined interactions between the process parameters, using statistical modelling techniques is better and increasingly common way. One such approach is the response surface methodology (RSM), a collection of statistical and mathematical techniques useful in many engineering applications, was demonstrated to be able to optimize a process with a minimal amount of experimental data. As a statistical tool, RSM can model the impact of various process factors, both individually and through their cumulative interactions, providing an indication of best combination of parameters and response prediction \[[@B34]\]. In recent years, artificial neural network (ANN) is finding increasing use as a predictive tool in an extensive range of disciplines because of its ability to employ learning algorithms. ANN discerns also input--output relationships for complex and nonlinear multifactor systems using the generic structure and ability to learn from historical data \[[@B35], [@B36]\]. Recently, RSM and ANN methods have been used jointly for both modelling and optimizing natural product extraction processes and biological activities, and the obtained models showed strong correlation with experimental results \[[@B35], [@B36]\].

On the other hand, despite the intensive research activities carried out in the past decades, it was estimated that less than 10% of the known plant species in the world has been studied for antimicrobial activities, and data are lacking regarding their compositions and detailed antimicrobial mechanisms \[[@B37]\]. In this line, studies on the understanding of the mechanism of natural antimicrobial action, such as PPE, by the development of predictive mathematical models are still scarce. Furthermore, predictive inactivation models have been developed in liquid laboratory media that can mimic the microbial environment \[[@B38], [@B39]\].

As part of further research work pertaining to the exploration of the bioactive compounds and biological control against foodborne bacterial pathogens, in this study, PPE was optimized using RSM and ANN techniques to enhance simultaneously the total phenolic content (TPC), total flavonoid content (TFC), total anthocyanin content (TAC), and anti-*Staphylococcus aureus* and anti-*Salmonella enterica* subsp. *enterica* serovar *Typhimurium* activities. Equally, by skillfully using statistical approach (linear (ANOVA) and general (ANCOVA) models), results from this study provide insight into PPE effectiveness against *S. aureus* and *S. enterica*.

To the best of our knowledge, data on (i) the comparison of RSM and ANN techniques for pomegranate peel optimization for bioactive compounds and biological control and (ii) intensive investigation of the inactivation mode against two dominant foodborne pathogens are not available in the literature.

2. Materials and Methods {#sec2}
========================

2.1. Plant Material {#sec2.1}
-------------------

Pomegranate fruits (*Punica granatum* L.) were obtained during commercial harvest in November 2017 from local farms of Sfax (N: 34.4426°, E: 10.4537°), a central coastal region in Tunisia. Peels were cleaned, washed with running water, air-dried under ambient conditions, and reduced to a fine powder using an electric grinder (Moulinex, France) to get 40-mesh size powder.

2.2. Extraction Conditions {#sec2.2}
--------------------------

Pomegranate peel powders were subjected to extraction through the maceration technique with ethanol (Novachim, Bucharest, Romania) as the solvent. Using a shaker (Heidolph, Unimax 2010; Elektro GmbH, Kelheim, Germany), extractions were performed in Erlenmeyer flasks (Schott Duran, Voor\'t labo, Eeklo, Belgium) containing 2.0 g of the pomegranate peel powder sample. All extractions were performed at 20°C (cold extraction) for different extraction time (*X*1: 10--60 min), agitation speed (*X*2: 120--180 rpm) and solvent/solid ratio (*X*3: 10--30). Extraction time and agitation speed were controlled from the panel of the instruments. After extraction, each mixture was centrifuged (Sorvall Biofuge Stratos, ThermoScientific, Hanau, Germany) at 13,000×*g* for 10 min at 4°C. For removal of peel particles, the supernatant was filtered through cotton wool and Whatman paper No. 1 (Whatman Ltd, England) and then collected. Each extraction mixture was evaporated in a rotary evaporator (Laborota 4000, Heidolph, Milan, Italy) at 40°C obtaining a yellow--brown residue from peels that were immediately analyzed. PPEs were weighed to calculate the recovery extraction (%). The extraction procedure was carried out in triplicates.

2.3. Phytochemical Study of PPE {#sec2.3}
-------------------------------

### 2.3.1. Quantification of the TPC {#sec2.3.1}

TPCs from PPE were quantified by using the Folin--Ciocalteu method \[[@B40]\] adapted for a 96-well plate assay. PPEs were evaluated at the final concentration of 100 *μ*g/mL. 100 *μ*L of 0.2 N Folin--Ciocalteu reagent (Sigma-Aldrich GmbH, Steinheim, Germany) was added to a 96-well plate (SPL Life Sciences, Pocheon, Gyeonggi, South Korea) containing 20 *μ*L of each PPE with 80% ethanol and kept for 5 min in darkness at room temperature. 80 *μ*L of sodium carbonate at 75 g/L (Scharlau, Barcelona, Spain) was added to each well, and the plate was then incubated for 30 min at room temperature with slightly shaking in the darkness. Absorbance at 725 nm was measured in the spectrophotometer (PG Instrument Ltd. Model T60, United Kingdom). Gallic acid at 0--200 *μ*g/L (Sigma-Aldrich GmbH, Steinheim, Germany) was applied as standard. Results were expressed as mgGA equivalents/g dry sample (mg GAE/g) using the linear equation based on the calibration curve. Each assay was carried out in triplicates.

### 2.3.2. Quantification of the TFC {#sec2.3.2}

TFCs in PPE samples were determined using the AlCl~3~ colorimetric method \[[@B41]\] adapted to 96-well plate. In brief, 100 *μ*L of 2% AlCl~3~ (Scharlau, Barcelona, Spain) was added to 100 *μ*L of each PPE in ethanol, and the plate was then incubated for 15 min at room temperature in the dark. The absorbance was determined at 430 nm. PPEs were evaluated at the final concentration of 100 *μ*g/mL. Quercetin at 0--50 *μ*g/mL (Sigma-Aldrich GmbH, Steinheim, Germany) was used as the standard. The total flavonoid contents were expressed as milligrams of quercetin equivalents mg QE/g of PPE. All the experiments were carried out in triplicates.

### 2.3.3. Quantification of the TAC {#sec2.3.3}

TAC was evaluated by the pH differential method using two buffer systems: 25 mM potassium chloride (Sigma-Aldrich GmbH, Steinheim, Germany) solution (pH 1.0) and 0.4 M sodium acetate (Loba Chemie Pvt. Ltd., Mumbai, India) buffer (pH 4.5). PPEs were mixed with the corresponding buffers, and absorbances were determined simultaneously at 510 and 700 nm, respectively, after 15 min of incubation at 23°C \[[@B42]\].$$\begin{matrix}
{A = \left( {A510\, - \, A700} \right)\text{ pH }1.0 - \left( {A510\, - \, A700} \right)\text{ pH }4.5.} \\
\end{matrix}$$

TAC, expressed as mg of cyanidin-3-glucoside equivalents per 100 g of PPE (mg cy-3-glu/100 g), had been calculated as follows:$$\begin{matrix}
{\text{TAC} = \frac{\left( {A \times \text{MW} \times 1000} \right)}{\varepsilon},} \\
\end{matrix}$$where *A*: absorbance; MW: molecular weight (449.2 g/mol); and *ε*: molar absorptivity of cyanidin-3-glucoside (26,900 M^−1^·cm^−1^).

2.4. Antibacterial Assays {#sec2.4}
-------------------------

### 2.4.1. Bacterial Strains and Culture Conditions {#sec2.4.1}

Target bacteria strains were obtained from international culture collections (ATCC). They included Gram-positive bacterium: *Staphylococcus aureus* ATCC 6538 and a Gram-negative bacterium: *Salmonella enterica* subsp. *enterica serovar Typhimurium* ATCC 14028. *S. aureus* ATCC 6538 was grown on Chapman medium (Oxoid, Hampshire, United Kingdom), and *S. enterica* ATCC 14028 was cultivated on Xylose Lysine Deoxycholate (XLD, Oxoid CM0469, Basingstoke, United Kingdom) at 37°C for 24 h. For antagonist tests, the final inoculum concentration used for each indicator bacterium was 10^6^ CFU/ml \[[@B43]\].

### 2.4.2. Determination of Minimum Inhibitory Concentrations (MICs) {#sec2.4.2}

The MIC of each PPE was determined against *S. aureus* ATCC 6538 and S*. enterica* ATCC 14028. The test was performed in sterile 96-well microplates with a final volume in each microplate well of 100 *μ*l. A stock solution of each extract, ranged between 0.0487 and 6.24 mg/mL, was prepared. To each test well, 10 *μ*l of cell suspension was added to final inoculum concentration of 10^6^ CFU/ml of bacterium. Positive growth control well consisted of *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028, respectively, growth in Chapman and XLD media. Dimethyl sulfoxide (DMSO) (Loba Chemie Pvt. Ltd., Mumbai, India)/water (1/9) was used as the negative control. The plates were then covered with sterile plate covers and incubated for 24 h \[[@B44]\]. MIC was defined as the lowest concentration of each extract in which the microorganism did not demonstrate visible growth after incubation. As an indicator of microorganism growth, 25 *μ*l of Thiazolyl Blue Tetrazolium Bromide (MTT) (Sigma-Aldrich, Taufkirchen, Germany), indicator solution (0.5 mg/mL) dissolved in sterile water was added to the wells and incubated at 30 min. The colourless tetrazolium salt acts as an electron acceptor and was reduced to a red-coloured formazan product by biologically active organisms. Where microbial growth was inhibited, the solution in the well remained clear after incubation with MTT. The determinations of MIC values were done in triplicates.

2.5. Box--Behnken Design and Optimization by RSM {#sec2.5}
------------------------------------------------

The extraction methodology was developed following the Box--Behnken design, and RSM was used to analyze the relationship between the measured responses and the individual and combined effects. Significant variables were optimized for enhanced phytochemical contents (TPC, TFC, and TAC), and anti-*S. aureus* and anti-*S. enterica* activities employing the Box--Behnken design \[[@B45]\].

The extraction time, agitation speed, and solvent/solid ratio were analyzed at three levels low, medium, and high coded as (−1), (0), and (+1), respectively, in fifteen runs. These variables: extraction time (*X*1: −1 : 10; 0 : 35; +1 : 60 min), agitation speed (*X*2: −1 : 120; 0 : 150; +1 : 180 rpm), and solvent/solid ratio (*X*3: −1 : 10; 0 : 20; +1 : 30) were selected for studying the effect and significance on TPC, TFC, TAC and the antibacterial activity.

The dummy variables were used to calculate the standard error. Each run was carried out in three replicates. The behavior of the system was explained by a second-order polynomial equation:$$\begin{matrix}
{Y = \beta_{0} + \left. \sum\beta_{i}X_{i} + \left. \sum\beta_{ij}X_{i}X_{j} + \left. \sum\beta_{ii}X_{i}^{2}, \right. \right. \right.} \\
\end{matrix}$$where *Y* is the predicted response, *β*~0~ is the offset term, *β*~*i*~ is the linear effect, βii is the squared effect, *β*~*ij*~ is the interaction effect, and *X*~*i*~ is the coded value of independent variables under study. This design was used to evaluate the main effects, interaction effects, and quadratic effects. It is also used to optimize the levels of parameters for enhancing the five responses. The statistical software Minitab 15.0 version was used for the experimental design and data analysis. Three-dimensional response surface plots were drawn to illustrate the relationship between the responses and the experimental levels of each independent variable. Optima levels of the variables for the maximum TPC, TFC, TAC, and the antibacterial activity was determined by the response optimizer tool of the software.

2.6. ANN-Based Modelling {#sec2.6}
------------------------

To forecast nonlinear processes via neural networks, the network type Multilayered Perceptron (MLP) was used \[[@B46], [@B47]\]. These analyses can be used to generate a system that would support forecast procedures. Modelling of the MLP network was achieved via tanh.

In this study, in order to guarantee the simplest network design, the networks were constructed with one hidden layer: the input layer consists of three neurons (*X*1, *X*2, and *X*3), while the output layer had five neurons (TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activities). To measure the performance of ANN models for approximating the desired output of the five responses, the coefficient of determination (*R*^2^) was calculated. In fact, *R*^2^ can be defined as a standard criterion for the evaluation of statistical performance and employed to verify the accuracy of the predictive ability of the assembled models \[[@B48]\]. The training data set was applied to train the ANN to locate the overall comprehensive model between its inputs and outputs. The test data were used to validate and corroborate the predictive value of the expanded networks.

Neural Network module of [STATISTICA]{.smallcaps} 8.0 software was used in modelling the ANN. The data were categorized into two parts: training (80%) and testing (20%). In the network, there were three inputs and one output, corresponding to the TPC, TFC, TAC, and the antibacterial activity. The hidden neurons were optimized by building various MLP with hidden nodes from 1 to 10. Networks with hidden nodes greater than 10 were not developed because of the predictive capabilities decreasing with the decrease in the number of intermediate units.

2.7. Time-Kill Assay of PPE on Viable Counts of *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 {#sec2.7}
--------------------------------------------------------------------------------------------------

The PPE effect on the inhibition of *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 was assessed by sequential sampling and counting viable bacteria, respectively, in the Chapman and the XLD broth. Firstly, *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 growth reached the beginning of the exponential phase (∼10^4^ CFU/ml). After three hours of incubation time, PPEs were added separately in four different concentrations (0.171, 0.342, 0.684, and 1.368 mg/mL for *S. aureus* and 0.555, 1.11, 2.22, and 4.44 for *S. enterica*) then incubated 37°C for 24 hours. At various points of incubation time: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 16, 18, 20, 22, 24, and 26 hours, the numbers of CFU were determined by plating the samples on Chapman agar for *S. aureus* ATCC 6538 and XLD agar for *S. enterica* ATCC 14028 and then counting of the colonies that appeared. Controls were prepared under the same experimental conditions as mentioned above but without PPE addition. Each test was performed in triplicates.

2.8. Statistical Analysis {#sec2.8}
-------------------------

Measurements were carried out in triplicates and repeated three times. A one-way analysis of variance (ANOVA) and Tukey\'s post-hoc test were performed to determine significant differences between the responses using the Statistical Package for the Social Sciences (SPSS) software (SPSS Ltd. Woking, United Kingdom). Means and standard errors were calculated. Differences among the mean values of the various responses were determined by the least significant difference test. A probability level of *p* \< 0.05 was used in testing the statistical significance of all the experimental data.

Plate count data were converted to logarithms prior to their statistical treatment. Linear mixed models assuming the error to compare CFU values among treatments with different time periods were used. Mixed models were fitted using SPSS 19 and followed by post hoc contrasts through the origin. The interpretation of the statistical output of a mixed model requires an understanding of how to explain the relationships among the fixed and random effects.

3. Results and Discussion {#sec3}
=========================

The effect of extraction time, agitation speed, and solvent/solid ratio on the recovery extraction of PPE was shown in [Table 1](#tab1){ref-type="table"}. Recovery extraction of different experimental runs ranged between 14.4 ± 0.51 and 19.98 ± 0.95%. Among the fifteen runs, the highest (*p* \< 0.05) PPE recovery extraction was recorded in run 2 with a value of 19.98 ± 0.95%. A similar trend has been observed by Malviya et al. \[[@B49]\] studying the effect of using different solvents on the extraction yield from pomegranate peels. In fact, these authors reported that recovery extraction was about 15%.

To develop an empirical model, an experimental design has been formulated by examining the interaction of different associated parameters *X*1 (time of extraction), *X*2 (agitation speed), and *X*3 (solvent/solid ratio). The design arrangement and experimental results of the extraction are shown in [Table 1](#tab1){ref-type="table"}. In order to evaluate the fitness of response function, a total of 15 designed experiments were conducted for optimizing *X*1, *X*2, and *X*3 in a multivariable system. According to equation ([3](#EEq3){ref-type="disp-formula"}), *Y*~TPC~, *Y*~TFC~, *Y*~TAC~, *Y*~anti-*S.\ aureus*~, and *Y*~anti-*S.\ enterica*~ were calculated into the generalized model. Equally, the linear and quadratic effects of independent variables (*X*1, *X*2, and *X*3) of the multiple regression coefficients were calculated, and their interactions were also analyzed for regression coefficients in the RSM study.

3.1. Model Fitting and Analysis of Response Surfaces {#sec3.1}
----------------------------------------------------

The adequacy and fitness of the models were judged by the lack-of-fit significance and *R*^2^. For all responses, the statistical analysis indicated that the proposed model was adequate, possessing no significant lack-of-fit, and with very satisfactory values of *R*^2^. The latter was estimated to be 98.39, 89.26, 86.41, 97.98, and 97.98% for the TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activities, respectively. As shown in [Table 2](#tab2){ref-type="table"}, with no lack-of-fit, *p* values of the total model of all responses were less than 0.05. Besides, *F* values from all regression models (*F*~\[TPC\]~ = 33.87, *p*=0.001; *F*~\[TFC\]~ = 4.62, *p*=0.043; *F*~\[TAC\]~ = 3.53, *p*=0.049; *F*~\[anti-*S.\ aureus*\]~ = 26.88, *p*=0.001 and *F*~\[anti-*S.\ enterica*\]~ = 26.13, *p*=0.001) were significant. Second-order polynomial equations were used to study the relation between the input process variables (*X*1, *X*2, and *X*3) and their five respective responses. So, the second-order polynomial coefficient for each term of the equation was determined through multiple regression analysis using RSM.

### 3.1.1. Effect of Extraction Variables on Phytochemical Contents {#sec3.1.1}

*(1) TPC*. As shown in [Table 1](#tab1){ref-type="table"}, the TPCs of different experimental runs ranged between 70.2 and 123.8 mg GAE/g. The data obtained from the experiments were used to estimate the coefficients by regression analysis. *p* values were used to evaluate the significance of different coefficients, which provides the information required to understand the interaction patterns among the experimental variables. *p*-values less than 0.05 are always accepted as the values for statistical significance with a confidence level greater than 95%, and smaller *p* values refer to a larger significance of the respective coefficient. As presented in [Table 2](#tab2){ref-type="table"}, the linear (*p*=0.002), the quadratic (*p* ≤ 0.001), and interaction (*p*=0.018) coefficients were significant. The response of activity can be expressed in the following regression equation:$$\begin{matrix}
{Y_{\text{TPC}} = 70 - 9.5 \times X1 - 3.312 \times X2 - 8.137 \times X3 + 29.9 \times X1^{2} + 11.225 \times X2^{2} + 9.025 \times X3^{2} + 2.175 \times X1X2 + 0.875 \times X1X3 + 10.95 \times X2X3.} \\
\end{matrix}$$

The quadratic term coefficients (*X*1^2^, *X*2^2^, and *X*3^2^) and the interaction coefficients (*X*1*X*2, *X*1*X*3, and *X*2*X*3) have a positive effect while *X*1, *X*2, and *X*3 exhibit a negative effect on the TPC. A longer extraction time presents a negative effect on the TPC. Meanwhile, no influence of this parameter was found, indicating that there is no benefit in using contact times greater than 15 min. Similar effects of time (10--30 min) on TPC pomegranate peel extracted by ultrasonic procedure was observed \[[@B33]\]. On the same line, when the solvent/solid ratio increased from 10 to 30, the extraction efficiency of the TPC did not vary significantly. Dailey et al. in 2015 and Medouni-Adrar et al. in 2015 found that the extraction time and sample-to-solvent ratios have respectively a negative effect on the Macadamia (*Macadamia tetraphylla*) skin waste and the Algerian skin grape TPCs \[[@B50], [@B51]\]. The 3-D response surface plot of the regression equation ([4](#EEq4){ref-type="disp-formula"}) was presented in [Figure 1(a)](#fig1){ref-type="fig"}. From the graphical representation, it can be concluded that the TPC does not depend on the agitation speed and extraction time. In this regard, the TPC increased with the increase of the solvent/solid ratio from 12 to 18, and then slightly decreased from 19 to 23. With a minimal value of extraction time, the maximum of TPC in the PPE was observed. Likewise, Dailey and Vuong observed that TPC did not change significantly by extraction time (10--30 min) of *Macadamia tetraphylla* \[[@B50]\]. However, Pinelo et al. showed that the TPC of grape extracts decrease with the increase of the extraction time (30--90 min) \[[@B52]\].

Based on numerical optimization, the predicted models with the maximum TPC was 124.5 mg GAE/g, when the optimal values of test factors were: time of extraction (10 min), agitation speed (135 rpm) and solvent/solid ratio (15) ([Table 1](#tab1){ref-type="table"}, [Figure 2(a)](#fig2){ref-type="fig"}). In fact, an increase of 56.224% was shown between the original (70 mg GAE/g) and the optimized TPC (124.5 mg GAE/g).

*(2) TFC*. The maximum and minimum TFCs were 37.11 and 22.00 mg QE/g, respectively ([Table 1](#tab1){ref-type="table"}). The quadratic models (*X*1^2^, *X*2^2^, and *X*3^2^) have a positive effect on TFC while linear and interaction models of time of extraction and solvent/solid ratio have negative effects. The generalized second-order polynomial equation proposed for TFC is as follows:$$\begin{matrix}
{Y_{\text{TFC}} = 23.037 - 1.731 \times X1 - 2.34 \times X2 - 1.016 \times X3 + 6.666 \times X1^{2} + 0.384 \times X2^{2} + 4.67 \times X3^{2} + 0.588 \times X1X2 - 1.875 \times X1X3 - 1.092 \times X2X3.} \\
\end{matrix}$$

[Figure 1(b)](#fig1){ref-type="fig"} shows the influence of the three studied parameters on the TFC. In this regard, the increase of agitation speed from 140 rpm to 150 rpm increased the TFC. The increase of extraction time and solvent/solid ratio has a negative effect on the TFC ([Figure 1(b)](#fig1){ref-type="fig"}). Dailey and Vuong has demonstrated the negative interaction between the time and ratio on TFC \[[@B50]\]. On the contrary, Sood and Gupta observed that the interaction ((ethanol/pomegranate powder ratio) and (ethanol/extraction time)) has a positive effect on the TFC \[[@B34]\].

Moreover, greater extraction time (*X*1), having a negative impact on the TPC and TFC, increase the chances of free radicals formation which can be scavenged by phenolic compounds \[[@B53], [@B54]\]. Equally, plant cells contain enzymes, in particular polyphenol oxidase, capable of altering the phenolic compounds and contribute to enzymatic browning reactions \[[@B55]\]. Furthermore, excessive time is not useful to extract more phenolic compounds \[[@B56], [@B57]\]. The optimization allowed attaining a maximum TFC of 36.292 mg QE/g with a 63.47% of increase compared with standard conditions. To get this TFC, the time of extraction was set at 8.5 min, agitation speed at 132 rpm, and solvent/solid ratio at 11.25.

*(3) TAC*. As shown in [Table 2](#tab2){ref-type="table"}, the interaction effect was the most significant (*F*-value of 5.42, *p*=0.031), followed by the linear effects (*F* values of 4.25, *p*=0.048).

The regression equation showing the mathematical relationship of process variables for the TAC is as follows:$$\begin{matrix}
{Y_{\text{TAC}} = 4.633 + 1.546 \times X1 + 2.435 \times X2 - 0.572 \times X3 + 0.731 \times X1^{2} + 1.147 \times X2^{2} + 2.872 \times X3^{2} + 0.753 \times X1X2 - 1.192 \times X1X3 + 2.276 \times X2X3.} \\
\end{matrix}$$

[Figure 1(c)](#fig1){ref-type="fig"} showed that the increment in agitation speed had both positive and negative (or dual) effects on the TAC. More precisely, enhancement of the intensity level of the agitation speed up to 130 rpm led to a negligible increase in the TAC. By a further increment of the intensity level \>160 rpm, the TAC was decreased. In a fixed extraction time, the TAC can also be increased by the increasing the solvent/solid ratio up to 15.5 ([Figure 1(c)](#fig1){ref-type="fig"}).

The optimization allowed as well a maximum TAC of 7.182 mg cy-3-glu/100 g under the following conditions: time of extraction of 35 min, agitation speed of 155 rpm, and solvent/solid ratio of 17. These conditions contributed to a 64.6% increase of TAC in comparison with standard conditions.

### 3.1.2. Effect of Extraction Variables on the Antibacterial Activity {#sec3.1.2}

*(1) Anti-S. aureus activity*. The anti-*S. aureus* activity (MIC, *Y*~anti-*S.\ aureus*~) of PPE, varied from 0.097 to 1.56 mg/ml, was significantly (*p* \< 0.05) affected by the quadratic effects (*F* values of 78.07, *p* ≤ 0.001) (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}). The response of anti-*S. aureus* activity can be expressed by the following regression equation:$$\begin{matrix}
{Y_{\text{anti} - S\text{. aureus}} = 1.56 - 0.033 \times X1 + 0.038 \times X2 - 0.014 \times X3 - 0.596 \times X1^{2} - 0.519 \times X2^{2} - 0.696 \times X3^{2} + 0.025 \times X1X2 + 0.024 \times X1X3 - 0.15 \times X2X3.} \\
\end{matrix}$$

Equation ([7](#EEq7){ref-type="disp-formula"}) showed that *X*2 and the interaction coefficients (*X*1*X*2 and *X*1*X*3) have a positive effect, while, quadratic term coefficients and the single effect of *X*1 and *X*3 showed a negative effect on the MIC~anti-*S.\ aureus*~ activity. The 3D response surfaces based on equation ([7](#EEq7){ref-type="disp-formula"}) was presented in [Figure 1(d)](#fig1){ref-type="fig"}: the dark violet color regions in each response surface plot represent the regions where maximum anti--*S. aureus* activity was observed. At a high agitation speed (180 rpm), and by increasing the extraction time, MIC ~anti-*S.\ aureus*~ activity was decreased with a maximum at a level ranged between 15 and 20 min. The interaction effect *X*1*X*3 showed that the anti-*S. aureus* activity goes to a maximum activity at 0.2 mg/ml at a high value of extraction time (60 min) and at a minimum level of ratio. While, minimum anti-*S. aureus* activity was obtained at the middle levels of extraction time (30--40 min), agitation speed (145--155 rpm), and solvent/solid ratio (17--22). At optimized conditions extraction time at 11 min, agitation speed 125 rpm and solvent/solid ratio 12, anti-*S*. *aureus* activity remarkably decreased from 1.56 to 0.171 mg/mL.

PPE is widely recognized for its effectiveness against a broad spectrum of bacterial pathogens. Our results are in the same line with the obtained results reported by Dahham et al. and Ismail et al. who studied the antimicrobial effect of PPE against *S. aureus* \[[@B58], [@B59]\].

*(2) Anti-S. enterica activity*. Regression analysis data such as estimated coefficients and *p*-value were shown in [Table 2](#tab2){ref-type="table"}, and the response of anti-*S. enterica* activity was predicted by the following regression equation:$$\begin{matrix}
{Y_{\text{anti} - S\text{. enterica}} = 0.78 + 0.011 \times X1 + 0.008 \times X2 + 0.003 \times X3 - 0.341 \times X1^{2} - 0.188 \times X2^{2} - 0.263 \times X3^{2} + 0.095 \times X1X2 + 0.027 \times X1X3 - 0.091 \times X2X3.} \\
\end{matrix}$$

All linear and interactions (*X*1*X*2 and *X*1*X*3) exhibit a positive effect on anti-*S. enterica* activity, while quadratic term coefficients (*X*1^2^, *X*2^2^, and *X*3^2^) and interaction *X*2*X*3 present a negative effect. At a constant ratio of solvent to solid (*X*3), the increasing of extraction time (*X*1) to 60 min and a minimal speed agitation (*X*2) to 120 rpm increases the anti-*S. enterica* activity ([Figure 1(e)](#fig1){ref-type="fig"}). The best conditions to produce the minimal MIC against *S. enterica*, at 0.555 mg/ml, were resulted in the following responses: time of extraction, 12 min; agitation speed, 129.675 rpm, and solvent/solid ratio; 22.5. These conditions contributed to an increase of 71.19 % in MIC~anti-*S.\ enterica*~ activity in comparison with standard conditions.

Wafa et al. reported that MICs values of pomegranate ethanolic extract against *Salmonella* strains ranged between 10.75 and 12.5 mg/mL \[[@B19]\]. Results reported by Choi et al. showed that the MIC values of PPE against *Salmonella* strains ranged from 0.0625 to 1 mg/mL \[[@B60]\]. Among the tested *Salmonella* strains, *Salmonella typhimurium* and *Salmonella anatum* were found to be more sensitive with an MIC value of 0.25 mg/mL \[[@B61]\]. Different inhibition profile of PPE against microorganisms could be in part due to the different extraction solvents, the plant variety, variations in the geographical, and the climatic conditions \[[@B60]\].

3.2. Artificial Neural Network Prediction on Phytochemical Contents and Antibacterial Activity {#sec3.2}
----------------------------------------------------------------------------------------------

ANN has been widely used as a cutting-edge tool for the simulation and optimization of bioactive compounds extraction from different matrices \[[@B62], [@B63]\]. In this study, ANN was used in combination with an experimental design in order to obtain maximum phytochemical contents with the highest antibacterial activity. [Figure 2](#fig2){ref-type="fig"} showed the structure of the multilayer perceptron ANN model with a back-propagation learning algorithm, designed for the relevant process. The first step of ANN modelling was the optimization of a neural network with the aim of obtaining an ANN model with minimal dimension and minimal errors in training and testing. The design of experiments and their respective experimental yields were used for training the network. The input layer represents vectors constituted of noncoded variables: time of extraction, agitation speed, and solvent/solid ratio, and the output layer represents TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activities. In the ANN structure, the unit number in the hidden layer was set as 7, 4, 3, 10, and 6 for the node number \[[@B64], [@B65]\]. For TPC, the most suitable model is an MLP trained with 3 independent variables for the input parameters (3-7-1): 3 input neurons, 7 hidden neurons, and 1 output ([Figure 2(a)](#fig2){ref-type="fig"}). The results of the trained model were created with high *R*^2^ (*R*^2^ = 99.88% for test). The topology of the ANN architecture illustrated in Figures [2(b)](#fig2){ref-type="fig"}--[2(c)](#fig2){ref-type="fig"}, showed a neural structure of (3-4-1) and (3-3-1) respectively for TFC and TAC with *R*^*2*^ = 99.58 and 99.21%, respectively. For anti-*S. aureus* and *S. enterica* activities, the robustness network architecture with (3-10-1) and (3-6-1), respectively, were represented in Figures [2(d)](#fig2){ref-type="fig"}--[2(e)](#fig2){ref-type="fig"}. Furthermore, given *R*^*2*^ were 99.13 and 99.67%, which is totally satisfactory.

The predicted data by ANN model were given along with the RSM predicted and experimental values ([Table 1](#tab1){ref-type="table"}, [Figure 3](#fig3){ref-type="fig"}). In fact, for predicted ANN, the relative percent deviation between the phytochemical contents and the antibacterial activities obtained experimentally for the same extraction conditions were respectively: 1.005, 1.003, 1.004, 1.031, and 1.005% for the TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activities.

3.3. Comparison of RSM and ANN Models {#sec3.3}
-------------------------------------

For a comparison of both well trained ANN and RSM models, *R*^2^ and mean square error (MSE) were used as statistical indicators ([Table 1](#tab1){ref-type="table"}, [Figure 3](#fig3){ref-type="fig"}).$$\begin{matrix}
{\text{MSE} = \frac{1}{n}\sum\limits_{i - 1}^{n}\left( {Y_{\exp.} - Y_{\text{pred}.}} \right).} \\
\end{matrix}$$

Hence, for phytochemical contents and antibacterial activities, obtained results from RSM models indicated that the measured *R*^2^ between the observed and the predicted data were acceptable with *R*^2^ \> 70%. Furthermore, ANN models showed higher accuracies when compared with RSM models. The comparison between results with predicted outputs from ANN and RSM was shown in [Figure 3](#fig3){ref-type="fig"}. ANN model improved the adjustments in comparison with the RSM model. ANN model presents an improvement of 4.4, 26.66, 28, 4.8 and 5.5% in terms of *R*^2^ concerning the TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activities ([Figure 3](#fig3){ref-type="fig"}). To illustrate the difference between the mentioned variables, enlarged versions of the simulation output based on the ANN and RSM models are presented in [Figure 3](#fig3){ref-type="fig"}. The predictive superiority of the ANN model over the RSM model for data fitting and the estimation capability has already been demonstrated in previous studies \[[@B64]--[@B68]\].

3.4. Prediction of the Antibacterial Activity of PPE {#sec3.4}
----------------------------------------------------

To elucidate a better understanding of the PPE as an antibacterial agent, the linear (ANOVA) and general (ANCOVA) models were mathematically used to model the growth rate of *S. aureus* ATCC 6538 and *S. enterica* subsp. *enterica* serovar Typhimurium ATCC 14028. Challenge experiments were conducted to evaluate PPE effects on the growth *S. aureus* and *S. enteric*, respectively, in Chapman and XLD media. Therefore, *S. aureus* and *S. enterica* kinetics were performed using different concentrations of PPE (MIC, 2 × MIC, 4 × MIC, and 8 × MIC). To investigate the effects of PPE, *S. aureus* and *S. enterica* growth were followed during 26 h and evaluated with respect to the control (culture without PPE addition). Moreover, it should be noted that the PPE addition to bacterial cells was realized after 3 hours of incubation when growth reached the beginning of the exponential phase (Cell∼10^4^ CFU/ml).

Viable cell counts log~10~ (CFU/ml) in absence Control (0MIC) and in presence of 1 × MIC, 2 × MIC, 4 × MI and 8 × MIC of pomegranate peel extracts. The time of extracts addition was 3 hours. ±: Standard deviation of three replicates; Values with a different letter (a--e) within a row of the same time are significantly different (*p* \< 0.05); Values with a different letter (A--L) within a column of the same concentration are significantly different (*p* \< 0.05).

### 3.4.1. Influence of the PPE on In Vitro *S. aureus* and *S. enterica* Inhibition Using Linear Model (ANOVA) {#sec3.4.1}

A rapid killing action occurred at 1 hour after addition of all tested MICs (incubation time of 4 hours). For *S. aureus*, these population numbers were 0.74, 1.02, 1.32, and 1.85 log~10~ CFU/mL lower (*p* \< 0.05) than the control numbers. Meanwhile, for *S. enterica*, 1 h post PPE addition, at all tested MICs, PPE showed a reduction (*p* \< 0.05) of 0.24, 0.4, 0.71, and 1.15 log~10~ CFU/mL compared with control samples ([Table 3](#tab3){ref-type="table"}). At 4 × MIC, no viable cells were observed after 13 and 11h respectively for *S. aureus* and *S. entreica*. Interestingly, at 8 × CMI, the early logarithmic growth phase of *S. aureus* ATCC 6538 resulted in a rapid decrease during 5 hours, while 7 hours were enough to inhibit *S. enterica* ATCC 14028 ([Table 3](#tab3){ref-type="table"}). These results clearly demonstrated that PPE has bactericidal activity against the Gram-positive (*S. aureus* ATCC 6538) and the Gram-negative (*S. enterica* ATCC 14028) bacteria.

[Table 4](#tab4){ref-type="table"} shows the overall differences between 5 trials for each bacterium at all tested MICs (1 × MIC, 2 × MIC, 4 × MIC and 8 × MIC) and 20 different times. For one fixed time, significant differences (*p* \< 0.001) were observed between treatments trials and times (Trial × Time). The five treatment groups significantly increased the anti-*S. aureus* (*p* \< 0.001) and anti-*S. enterica* (*p* \< 0.001) activities. Indeed, this result confirmed the previous results showed in [Table 3](#tab3){ref-type="table"} where PPE exerts dose-dependent bactericidal effects.

### 3.4.2. Influence of the PPE on In Vitro *S. aureus* and *S. enterica* Inhibition Using General Linear Model (ANCOVA) {#sec3.4.2}

A descriptive statistics using a mixed model of the time-related survival of *S. aureus* and *S. enterica* following treatment with various PPE concentrations was presented in [Table 5](#tab5){ref-type="table"}. *p*-value \< 0.05 was always accepted value for statistical significance with confidence level \>95% and smaller *p* values refer to a larger significance of the respective coefficient \[[@B69], [@B70]\]. As shown in [Table 5](#tab5){ref-type="table"}, for *S. aureus*, a significant effect (*p* \< 0.05) was noticed at 0, 1, 2, 3, 4, and 5 hours. In fact, in the beginning of experimentation, the first 2 hours after PPE addition were primordial for *S. aureus* inhibition. Concerning *S. enterica* inhibition, 3 hours of post PPE addition was effective. In contrast, no significant differences (*p* \> 0.05) were found between groups at any time point 2 and 3 hours post PPE addition, respectively, on *S. aureus* and *S. enterica* inhibition ([Table 5](#tab5){ref-type="table"}).

The effects of treatments, time, and their interaction on the inhibition of *S. aureus* and *S. enterica* were shown in [Table 6](#tab6){ref-type="table"}. A significant interaction (*p* \< 0.05) between all treatments samples and bacterial growth time was remarked. With the lowest *p* value, 8 × MICs (Trial 5), and incubation was found highly significant (*p* \< 0.01) effect regarding inhibition of *S. aureus* and *S. enterica* ([Table 6](#tab6){ref-type="table"}). It is obvious that high concentrations of 1.368 mg/mL against *S. aureus*) and (4.44 mg/mL against *S. enterica*) coupled with time have an active action on inhibition of studied bacteria.

The covariance parameters are presented in [Table 7(A)](#tab7){ref-type="table"}. Intercept variances are estimated as 5.379 and 1.788 for *S. aureus* and *S. enterica*, respectively. The null hypothesis for this parameter is a variance of zero, which would indicate that a random effect is not needed, and the statistical test is called a Wald Z statistic \[[@B71]\]. For *S. aureus* and *S. enterica*, the two hypotheses Wald *Z* = 0.000 where *p*=0.015; for anti-*S. aureus* activity and *p*=0.018; for anti-*S. enterica* activity was accepted ([Table 7(A)](#tab7){ref-type="table"}). Equally, as illustrated in [Table 7(B)](#tab7){ref-type="table"} for fixed time, the two hypotheses Wald *Z* = 0.815, *p*=0.038 and Wald *Z* = 0.000, *p*=0.031 as well as Wald *Z* = 0.000, *p*=0.029 were accepted. Furthermore, results from [Table 7](#tab7){ref-type="table"} showed that interactions of the trial type and incubation time have an important role in inhibition of *S. aureus* and *S. enterica*.

4. Conclusion {#sec4}
=============

Recent years have witnessed an indisputable interest in plants for exploring and promoting their bioactive compounds in the health field. In this study, the use of pomegranate peel as a natural alternative source to produce biological compounds, phytochemical contents (TPC, TFC, and TAC), and anti-*S. aureus* and anti-*S. enterica* activities, has been evaluated and optimized. Both RSM and ANN have been used to generate the model on all five responses from PPE. The extraction time, agitation speed, and solvent/solid ratio of pomegranate peel markedly influenced phytochemical contents and antibacterial activity. Under optimal conditions, TPC (124.5 mg GAE/g), TFC (36.292 mg QE/g), TAC (7.182 mg cy-3-glu/100 g), MIC~anti-*S.\ aureus*~ (0.171 mg/mL), and MIC~anti-*S.\ enterica*~ (0.555 mg/mL) were maximal. Equally, this work highlights the great anti-*S. aureus* and anti-*S. enterica* effects of PPE at optimized conditions. The mode of action study confirms our results and indicates that PPE exerts a dose-dependent bactericidal effect against these foodborne bacterial pathogens. Therefore, PPE can be considered as a strong and promising tool for future application as a safe method for the preservation of food products.
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###### 

Box--Behnken design and ANN models of variables (in coded levels), with phytochemical contents (TPC, TFC, and TAC) and anti-*S. aureus* and *S.enterica* activity responses.

  Run order   (*X*1)    (*X*2)     (*X*3)    Recovery extraction (%)   Phytochemical content   Antibacterial activity                                                                                                                                                  
  ----------- --------- ---------- --------- ------------------------- ----------------------- ------------------------ --------- ------------------ -------- -------- ----------------- -------- -------- ----------------- ------- ------- ----------------- ------- -------
  1           10 (−1)   150 (0)    10 (−1)   18.45 ± 0.92^c^           123.8 ± 6.19^cd^        127.485                  128.671   37.11 ± 1.85^f^    35.249   37.06    4.78 ± 0.22^c^    4.607    4.817    0.39 ± 0.00^b^    0.34    0.395   0.195 ± 0.00^c^   0.188   0.193
  2           10 (−1)   180 (+1)   20 (0)    19.98 ± 0.95^d^           118.02 ± 5.91^c^        115.312                  118.15    30.02 ± 1.45^d^    28.892   30.006   4.64 ± 0.21^c^    4.884    4.828    0.39 ± 0.00^b^    0.492   0.382   0.195 ± 0.00^c^   0.171   0.195
  3           60 (+1)   150 (0)    10 (−1)   17.3 ± 0.86^b^            109.6 ± 4.48^bc^        106.637                  109.849   37.09 ± 1.84^f^    35.535   36.606   11.61 ± 0.52^h^   10.085   11.582   0.097 ± 0.00^a^   0.224   0.128   0.195 ± 0.00^c^   0.185   0.194
  4           35 (0)    150 (0)    20 (0)    17 ± 0.85^b^              70.02 ± 3.49^a^         70.00                    71.156    22.00 ± 1.22^a^    23.037   23.019   4.64 ± 0.21^c^    4.633    4.586    1.56 ± 0.00^d^    1.56    1.509   0.781 ± 0.00^b^   0.780   0.772
  5           10 (−1)   120 (−1)   20 (0)    15.6 ± 0.7^ab^            130 ± 6.47^d^           126.162                  129.789   33.35 ± 1.62^de^   34.749   33.507   3.71 ± 0.17^b^    2.520    3.81     0.39 ± 0.00^b^    0.464   0.386   0.39 ± 0.00^a^    0.325   0.393
  6           35 (0)    180 (+1)   10 (−1)   15 ± 0.75^a^              85.00 ± 4.23^ab^        84.125                   84.729    25.00 ± 1.22^b^    27.862   23.019   9.75 ± 0.46^g^    9.385    9.808    0.781 ± 0.00^c^   0.547   0.794   0.39 ± 0.00^a^    0.424   0.388
  7           60 (+1)   120 (−1)   20 (0)    15.15 ± 0.6^a^            99.91 ± 4.92^b^         102.712                  100.108   29.00 ± 1.44^cd^   30.108   28.917   3.94 ± 0.12^b^    3.406    4.033    0.39 ± 0.00^b^    0.347   0.411   0.195 ± 0.00^c^   0.197   0.198
  8           35 (0)    120 (−1)   10 (−1)   16.7 ± 0.45^b^            112.5 ± 5.61^bc^        112.65                   112.16    30.01 ± 1.5^d^     30.357   29.897   7.01 ± 0.33^f^    8.766    6.982    0.195 ± 0.00^e^   0.170   0.206   0.195 ± 0.00^c^   0.196   0.197
  9           35 (0)    150 (0)    20 (0)    14.4 ± 0.51^a^            70.00 ± 3.41^a^         70.00                    71.156    22.01 ± 1.02^a^    23.037   23.019   4.61 ± 0.21^c^    4.633    4.586    1.56 ± 0.00^d^    1.56    1.509   0.781 ± 0.00^b^   0.780   0.772
  10          35 (0)    150 (0)    20 (0)    17.85 ± 0.82^bc^          70.01 ± 3.33^a^         70.00                    71.156    22.00 ± 1.09^a^    23.037   23.111   4.64 ± 0.22^c^    4.633    4.586    1.56 ± 0.00^d^    1.56    1.509   0.781 ± 0.00^b^   0.780   0.772
  11          10 (−1)   150 (0)    30 (+1)   17.05 ± 0.79^b^           106.5 ± 5.25^bc^        109.462                  107.043   35.50 ± 1.75^e^    36.965   35.706   5.32 ± 0.20^d^    5.547    4.112    0.39 ± 0.00^b^    0.263   0.411   0.195 ± 0.00^c^   0.193   0.193
  12          60 (+1)   150 (0)    30 (+1)   15 ± 0.66^a^              95.8 ± 4.77^b^          92.112                   95.755    28.00 ± 1.39^c^    29.751   28.151   6.38 ± 0.30^e^    6.554    6.384    0.195 ± 0.00^e^   0.245   0.206   0.39 ± 0.00^a^    0.364   0.369
  13          35 (0)    120 (−1)   30 (+1)   17.27 ± 0.84^b^           73.6 ± 3.66^a^          74.475                   73.895    33.36 ± 1.66^de^   30.508   33.071   3.02 ± 0.14^a^    3.068    3.341    0.39 ± 0.00^b^    0.442   0.391   0.39 ± 0.00^a^    0.414   0.415
  14          35 (0)    180 (+1)   30 (+1)   17.35 ± 0.36^b^           89.9 ± 4.44^ab^         89.75                    89.397    24.00 ± 1.15^b^    23.643   24.154   14.86 ± 0.71^i^   12.792   14.434   0.195 ± 0.00^e^   0.219   0.197   0.39 ± 0.00^a^    0.381   0.382
  15          60 (+1)   180 (+1)   20 (0)    17 ± 0.49^b^              96.6 ± 4.81^b^          100.437                  96.482    28.06 ± 1.32^c^    26.605   28.151   7.89 ± 0.37^f^    9.484    7.961    0.781 ± 0.00^c^   0.475   0.797   0.39 ± 0.00^a^    0.363   0.374

Variables: extraction time (*X*1), agitation speed (*X*2), and solvent/solid ratio (*X*3). ±: Standard deviation of three replicates; Averages with different letters (a--i) in the same column, for each parameter, are different (*p* \< 0.05).

###### 

ANOVA results of process variables against TPC, TFC, TAC, anti-*S. aureus*, and anti-*S. enterica* activity responses.

  Responses       Regression   Sum of square   *F* value     *p* value    *R* ^2^   *R* ~adjusted~ ^2^
  --------------- ------------ --------------- ------------- ------------ --------- --------------------
  TPC             Linear       1347.15         24.51         0.002^*∗*^   98.39     95.48
  Quadratic       3735.17      67.96           0.000^*∗∗*^                          
  Interaction     501.60       9.13            0.018^*∗*^                           
  Total model     5583.92      33.87           0.001^*∗∗*^                          
                                                                                    
  TFC             Linear       76.072          3.24          0.079        89.26     72.92
  Quadratic       228.990      9.75            0.016^*∗*^                           
  Interaction     20.225       0.86            0.119                                
  Total model     325.287      4.62            0.043^*∗*^                           
                                                                                    
  TAC             Linear       69.208          4.25          0.048^*∗*^   86.41     71.95
  Quadratic       37.531       2.94            0.078                                
  Interaction     28.690       5.42            0.031^*∗*^                           
  Total model     135.429      3.53            0.049^*∗*^                           
                                                                                    
  *S. aureus*     Linear       0.022           2.18          0.153        97.98     94.33
  Quadratic       3.561        78.07           0.000^*∗∗*^                          
  Interaction     0.094        2.08            0.222                                
  Total model     3.678        26.88           0.001^*∗∗*^                          
                                                                                    
  *S. enterica*   Linear       0.001           1.77          0.215        97.92     94.17
  Quadratic       0.718        71.08           0.000^*∗∗*^                          
  Interaction     0.072        7.17            0.029^*∗*^                           
  Total model     0.809        26.13           0.001^*∗∗*^                          

^*∗*^ *p*=0.05; ^*∗∗*^*p*=0.001; ^*∗∗∗*^*p* \< 0.001.

###### 

Influence of the dose of PPE addition on the growth of *Staphylococcus aureus* ATCC 6538 and *Salmonella enterica* subsp. *enterica* serovar Typhimurium ATCC 14028 *in vitro* using linear model (ANOVA).

  *Staphylococcus aureus* ATCC 6538   *Salmonella enterica* subsp. *enterica* serovar typhimurium ATCC 14028                                                                                                                                                                 
  ----------------------------------- ------------------------------------------------------------------------ ------------------ ------------------ ------------------- ------------------ ---- ------------------ ------------------ ------------------- ----------------- -----------------
  0                                   4.00 ± 0.18^aAB^                                                         4.00 ± 0.19^aF^    4.00 ± 0.15^aH^    4.00 ± 0.17^aI^     4.00 ± 0.18^aF^    0    4.00 ± 0.16^aA^    4.00 ± 0.20^aI^    4.00 ± 0.16^aI^     4.00 ± 0.18^aH^   4.00 ± 0.19^aG^
  1                                   4.35 ± 0.21^aA^                                                          4.35 ± 0.20^aGH^   4.35 ± 0.19^aHI^   4.35 ± 0.20^aJ^     4.35 ± 0.21^aGH^   1    4.25 ± 0.17^aAB^   4.25 ± 0.18^aJ^    4.25 ± 0.20^aJ^     4.25 ± 0.17^aI^   4.25 ± 0.20^aH^
  2                                   4.80 ± 0.22^aAB^                                                         4.80 ± 0.24^aHI^   4.80 ± 0.22^aJ^    4.80 ± 0.19^aK^     4.80 ± 0.18^aHI^   2    4.50 ± 0.21^aB^    4.50 ± 0.22^aK^    4.50 ± 0.19^aK^     4.50 ± 0.21^aK^   4.50 ± 0.22^aI^
  3                                   5.02 ± 0.24^aAB^                                                         5.02 ± 0.22^aI^    5.02 ± 0.25^aK^    5.02 ± 0.20^aL^     5.02 ± 0.23^aI^    3    4.93 ± 0.24^aC^    4.93 ± 0.23^aL^    4.93 ± 0.24^aM^     4.93 ± 0.21^aL^   4.93 ± 0.24^aJ^
  4                                   5.34 ± 0.25^eAB^                                                         4.63 ± 0.22^dH^    4.35 ± 0.19^cI^    4.05 ± 0.19^bI^     3.52 ± 0.16^aE^    4    5.15 ± 0.24^dC^    4.91 ± 0.22^cdL^   4.75 ± 0.22^cL^     4.44 ± 0.21^bK^   4.00 ± 0.19^aG^
  5                                   6.57 ± 0.32^eB^                                                          4.60 ± 0.22^dH^    4.20 ± 0.20^cHI^   3.81 ± 0.180^bH^    3.01 ± 0.14^aD^    5    5.80 ± 0.27^dD^    4.80 ± 0.23^cL^    4.54 ± 0.21^bcK^    4.21 ± 0.00^bI^   3.22 ± 0.00^aF^
  6                                   7.09 ± 0.34^eBC^                                                         4.50 ± 0.21^dH^    4.15 ± 0.19^cH^    3.70 ± 0.17^bH^     2.51 ± 0.12^aC^    6    6.02 ± 0.28^dE^    4.50 ± 0.21^cK^    4.22 ± 0.20^bcIJ^   4.00 ± 0.18^bH^   2.55 ± 0.12^aE^
  7                                   8.25 ± 0.39^eBC^                                                         4.24 ± 0.18^dG^    3.60 ± 0.17^cG^    3.22 ± 0.15^bG^     1.89 ± 0.09^aB^    7    6.15 ± 0.29^dEF^   4.30 ± 0.19^cJ^    3.81 ± 0.18^bH^     3.58 ± 0.17^bG^   2.00 ± 0.08^aD^
  8                                   8.52 ± 0.16^eBC^                                                         3.91 ± 0.18^dF^    3.44 ± 0.16^cF^    3.00 ± 0.14^bF^     1.00 ± 0.00^aA^    8    6.25 ± 0.29^eF^    4.00 ± 0.19^dI^    3.45 ± 0.16^cG^     3.00 ± 0.12^bF^   1.75 ± 0.07^aC^
  9                                   9.02 ± 0.43^eC^                                                          3.65 ± 0.17^dE^    3.00 ± 0.13^cE^    2.61 ± 0.12^bE^     1.00 ± 0.00^aA^    9    6.45 ± 0.30^dFG^   3.51 ± 0.16^cH^    3.33 ± 0.15^cG^     2.54 ± 0.12^bE^   1.33 ± 0.06^aB^
  10                                  9.32 ± 0.44^dCD^                                                         3.11 ± 0.14^cD^    2.74 ± 0.13^bD^    2.42 ± 0.11^bD^     1.00 ± 0.00^aA^    10   6.55 ± 0.31^dG^    3.26 ± 0.15^cG^    3.00 ± 0.14^cF^     2.11 ± 0.10^bD^   1.00 ± 0.00^aA^
  11                                  9.56 ± 0.45^eCD^                                                         2.77 ± 0.13^dC^    2.41 ± 0.11^cC^    2.00 ± 0.09^bC^     1.00 ± 0.00^aA^    11   6.74 ± 0.32^eGH^   3.04 ± 0.15^dF^    2.71 ± 0.13^cE^     1.75 ± 0.08^bC^   1.00 ± 0.00^aA^
  12                                  9.80 ± 0.47^eCD^                                                         2.40 ± 0.11^dBC^   1.90 ± 0.09^cB^    1.55 ± 0.07^bB^     1.00 ± 0.00^aA^    12   6.85 ± 0.33^eH^    2.75 ± 0.14^dE^    2.42 ± 0.11^cD^     1.44 ± 0.06^bB^   1.00 ± 0.00^aA^
  14                                  10.52 ± 0.50^dD^                                                         2.35 ± 0.11^cBC^   1.44 ± 0.07^bAB^   1.22 ± 0.05^abAB^   1.00 ± 0.00^aA^    14   6.98 ± 0.33^dH^    2.22 ± 0.10^cD^    1.90 ± 0.09^bC^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  16                                  10.77 ± 0.51^dCD^                                                        2.25 ± 0.10^cB^    1.20 ± 0.05^bAB^   1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    16   7.02 ± 0.30^dH^    1.75 ± 0.07^cC^    1.51 ± 0.07^bB^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  18                                  11.02 ± 0.52^cCD^                                                        2.14 ± 0.10^bAB^   1.10 ± 0.03^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    18   7.12 ± 0.29^dHI^   1.66 ± 0.07^cBC^   1.25 ± 0.06^bAB^    1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  20                                  11.25 ± 0.50^cD^                                                         2.00 ± 0.07^bAB^   1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    20   7.25 ± 0.33^cHI^   1.44 ± 0.06^bB^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  22                                  11.36 ± 0.54^cD^                                                         1.74 ± 0.08^bAB^   1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    22   7.35 ± 0.33^dJ^    1.25 ± 0.05^bAB^   1.00 ± 0.00^aA^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  24                                  11.50 ± 0.39^cD^                                                         1.25 ± 0.07^bA^    1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    24   7.53 ± 0.34^bJ^    1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^
  26                                  11.55 ± 0.55^cD^                                                         1.00 ± 0.06^bA^    1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^    26   7.55 ± 0.36^bJ^    1.00 ± 0.00^aA^    1.00 ± 0.00^aA^     1.00 ± 0.00^aA^   1.00 ± 0.00^aA^

###### 

Statistics test of main and interaction effects of univariate mixed analyses of variance for all dependent variables and effects (Trial and Time) with 95% confidence intervals.

  Outcome                       Effect      Level number   Parameter number   *F*             df~num~/df~den~   *p* value
  ----------------------------- ----------- -------------- ------------------ --------------- ----------------- -----------
  *Fixed trial*                                                                                                  
  Anti-*S. aureus* activity     Intercept   1              1                  206.094^*∗*^    1/60              \<0.001
  Time                          20          19             0.657              19/60           0.845             
  Trial                         1           1              66.187^*∗*^        1/60            \<0.001           
  Time × trial                  20          19             1.291              19/60           0.224             
  Anti-*S. enterica* activity   Intercept   1              1                  66.171          1/60              1.000
  Time                          20          19             0.240              19/60           0.412             
  Trial                         1           1              84.122^*∗*^        1/60            \<0.001           
  Time × trial                  20          19             1.540              19/60           0.104             
                                                                                                                
  *Fixed time*                                                                                                   
  Anti-*S. aureus* activity     Intercept   1              1                  1226.229^*∗*^   1/90              \<0.001
  Trial                         1           1              46.654^*∗*^        1/90            \<0.001           
  Time                          5           4              3.616^*∗*^         4/90            0.009             
  Trial × time                  5           4              95.230^*∗*^        4/90            \<0.001           
  Anti-*S. enterica* activity   Intercept   1              1                  387.703^*∗*^    1/90              \<0.001
  Trial                         1           1              21.093^*∗*^        1/90            \<0.001           
  Time                          5           4              1.228              4/90            0.305             
  Trial × time                  5           4              15.225^*∗*^        4/90            \<0.001           

df~num~/df~den~ = degrees of freedom of numerator/denominator.

###### 

Analyses of covariance for all dependent variables and effect of *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 activities.

  Parameter         *Staphylococcus aureus* ATCC 6538   *Salmonella enterica* subsp. *enterica* serovar typhimurium ATCC 14028                                                                                                                 
  ----------------- ----------------------------------- ------------------------------------------------------------------------ ----- -------- -------------- --------- -------- ------- ---------- ----- -------- ------------- ------------ -----------
  Intercept         9.44                                2.432                                                                    60    3.88     0.000^*∗∗∗*^   4.573     14.306   6320    3203.043   0     1.973    1.000         −79955.35    92595.35
  Hour 0            −5.44                               3.44                                                                     60    −1.581   0.119          −12.321   1.441    −6316   4529.787   0     −1.394   1.000         −128327.77   115695.77
  Hour 1            −5.089                              3.44                                                                     60    −1.479   0.144          −11.97    1.792    −2070   4529.787   0     −0.457   1.000         −124081.77   119941.77
  Hour 2            −4.64                               3.44                                                                     60    −1.349   0.182          −11.521   2.241    −1820   4529.787   0     −0.402   1.000         −123831.77   120191.77
  Hour 3            −4.42                               3.44                                                                     60    −1.285   0.204          −11.301   2.461    −1420   4529.787   0     −0.313   1.000         −123431.77   120591.77
  Hour 4            −3.859                              3.44                                                                     60    −1.122   0.266          −10.74    3.022    −844    4529.787   0     −0.186   1.000         −122855.77   121167.77
  Hour 5            −2.623                              3.44                                                                     60    −0.763   0.449          −9.504    4.258    −89     4529.787   0     −0.020   1.000         −122100.77   121922.77
  Hour 6            −2.079                              3.44                                                                     60    −0.605   0.548          −8.961    4.801    166     4529.787   0     0.037    1.000         −121845.77   122177.77
  Hour 7            −1.248                              3.44                                                                     60    −0.363   0.718          −8.129    5.633    352     4529.787   0     0.078    1.000         −121659.77   122363.77
  Hour 8            −1.018                              3.44                                                                     60    −0.296   0.768          −7.9      5.863    348     4529.787   0     0.077    1.000         −121663.77   122359.77
  Hour 9            −0.672                              3.44                                                                     60    −0.196   0.846          −7.554    6.208    422.8   4529.787   0     0.093    1.000         −121588.97   122434.57
  Hour 10           −0.51                               3.44                                                                     60    −0.148   0.882          −7.392    6.37     500     4529.787   0     0.110    1.000         −121511.77   122511.77
  Hour 11           −0.712                              3.44                                                                     60    −0.207   0.837          −7.593    6.169    491     4529.787   0     0.108    1.000         −121520.77   122502.77
  Hour 12           −0.665                              3.44                                                                     60    −0.193   0.847          −7.546    6.216    511     4529.787   0     0.113    1.000         −121500.77   122522.77
  Hour 14           −0.181                              3.44                                                                     60    −0.053   0.958          −7.062    6.7      304     4529.787   0     0.067    1.000         −121707.77   122315.77
  Hour 16           −0.029                              3.44                                                                     60    −0.008   0.993          −6.91     6.852    11      4529.787   0     0.002    1.000         −122000.77   122022.77
  Hour 18           0.096                               3.44                                                                     60    0.028    0.978          −6.785    6.977    −44     4529.787   0     −0.010   1.000         −122055.77   121967.77
  Hour 20           0.205                               3.44                                                                     60    0.060    0.953          −6.676    7.086    −70     4529.787   0     −0.015   1.000         −122081.77   121941.77
  Hour 22           0.183                               3.44                                                                     60    0.053    0.958          −6.698    7.064    −190    4529.787   0     −0.042   1.000         −122201.77   121821.77
  Hour 24           0.087                               3.44                                                                     60    0.025    0.980          −6.794    6.968    −120    4529.787   0     −0.026   1.000         −122131.77   121891.77
  Hour 26           0^a^                                0                                                                        60    ---      ---            ---                0^a^    0          ---   ---      ---           ---          ---
  Trial             −2.11                               0.733                                                                    60    −2.877   0.006^*∗∗*^    −3.577    −0.642   −1330   422.878    60    −3.145   0.003^*∗∗*^   −2175.882    −484.117
  Hour 0 × trial    2.11                                1.037                                                                    60    2.034    0.016^*∗*^     0.035     4.184    1330    598.04     60    2.224    0.009^*∗*^    133.741      2526.258
  Hour 1 × trial    2.11                                1.037                                                                    60    2.034    0.022^*∗*^     0.035     4.184    1330    598.04     60    2.224    0.011^*∗*^    133.741      2526.25
  Hour 2 × trial    2.11                                1.037                                                                    60    2.034    0.029^*∗*^     0.035     4.184    1330    598.04     60    2.224    0.015^*∗*^    133.741      2526.258
  Hour 3 × trial    2.11                                1.037                                                                    60    2.034    0.034^*∗*^     0.035     4.184    1330    598.04     60    2.224    0.030^*∗*^    133.741      2526.258
  Hour 4 × trial    1.691                               1.037                                                                    60    1.631    0.044          −0.3835   3.766    1054    598.04     60    1.762    0.039         −142.258     2250.258
  Hour 5 × trial    1.326                               1.037                                                                    60    1.279    0.046          −0.7486   3.401    755     598.04     60    1.262    0.044         −441.258     1951.258
  Hour 6 × trial    1.13                                1.037                                                                    60    1.090    0.206          −0.9447   3.205    586     598.04     60    0.980    0..049        −610.258     1782.258
  Hour 7 × trial    0.775                               1.037                                                                    60    0.748    0.208          −1.299    2.85     428     598.04     60    0.716    0.077         −768.258     1624.258
  Hour 8 × trial    0.574                               1.037                                                                    60    0.554    0.481          −1.5      2.649    352     598.04     60    0.589    0.258         −844.258     1548.258
  Hour 9 × trial    0.476                               1.037                                                                    60    0.459    0.548          −1.598    2.551    256.6   598.04     60    0.429    0.369         −939.658     1452.858
  Hour 10 × trial   0.376                               1.037                                                                    60    0.363    0.718          −1.698    2.451    144     598.04     60    0.241    0.511         −1052.258    1340.258
  Hour 11 × trial   0.358                               1.037                                                                    60    0.345    0.731          −1.716    2.432    115     598.04     60    0.192    0.748         −1081.258    1311.258
  Hour 12 × trial   0.275                               1.037                                                                    60    0.265    0.792          −1.799    2.349    29      598.04     60    0.048    0.861         −1167.258    1225.258
  Hour 14 × trial   0.111                               1.037                                                                    60    0.107    0.915          −1.96     2.185    14      598.04     60    0.023    0.981         −1182.258    1210.2584
  Hour 16 × trial   0.045                               1.037                                                                    60    0.043    0.966          −2.029    2.119    51      598.04     60    0.085    0.932         −1145.258    1247.258
  Hour 18 × trial   0.006                               1.037                                                                    60    0.006    0.995          −2.068    2.08     40      598.04     60    0.067    0.947         −1156.258    1236.258
  Hour 20 × trial   −0.029                              1.037                                                                    60    −0.028   0.978          −2.103    2.045    30      598.04     60    0.050    0.960         −1166.258    1226.258
  Hour 22 × trial   −0.029                              1.037                                                                    60    −0.028   0.978          −2.103    2.045    50      598.04     60    0.084    0.934         −1146.258    1246.258
  Hour 24 × trial   −0.015                              1.037                                                                    60    −0.015   0.988          0--2.09   2.059    30      598.04     60    0.050    0.960         −1166.258    1226.258
  Hour 26 × trial   0^a^                                0                                                                        ---   ---      ---            ---       ---      0^a^    0          ---   ---      ---           ---          ---

SE : Standard Error; df: Degrees of freedom; *t*: the Student *t*-statistic; Sig.: the *p* value (associated with the correlation); LB : Lower bound. UB : Upper bound; Trial 1: negative control; Trial 2 : 1 × MIC. Trial 3 : 2 × MIC; Trial 4 : 4 × MIC and Trial 5 : 8 × MIC; ^*∗*^*p* \< 0.05; ^*∗∗*^*p* \< 0.01; ^*∗∗∗*^*p* \< 0.001, ^a^This parameter is set to zero because it is redundant;^b^ Dependent variable: CFU.

###### 

*S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 behavior estimates of incubation time (hour) fixed effects with 95% confidence intervals^b^.

  Parameter        *Staphylococcus aureus* ATCC 6538   *Salmonella enterica* subsp*. enterica* serovar typhimurium ATCC 14028                                                                                                                 
  ---------------- ----------------------------------- ------------------------------------------------------------------------ ----- -------- -------------- -------- -------- ---------- --------- ----- -------- -------------- ---------- ----------
  Intercept        3.632                               0.289                                                                    90    12.565   0.000^*∗∗∗*^   3.058    4.206    3133.002   452.338   90    6.926    0.000^*∗∗∗*^   2234.353   4031.651
  Time             −0.144                              0.021                                                                    90    −6.68    0.000^*∗∗∗*^   −0.187   −0.101   1077.153   639.702   90    1.684    0.000^*∗∗∗*^   −193.727   2348.035
  Trial 1          1.455                               0.408                                                                    90    3.56     0.807          0.643    2.267    1263.938   639.702   90    1.976    0.639          −6.942     2534.819
  Trial 2          1.121                               0.408                                                                    90    2.743    0.306          0.309    1.933    1091.692   639.702   90    1.707    0.632          −179.188   2362.573
  Trial 3          1.084                               0.408                                                                    90    2.652    0.430          0.272    1.896    818.011    639.702   90    1.279    0.595          −452.869   2088.892
  Trial 4          0.8132                              0.408                                                                    90    1.989    ---            0.000    1.625    0^a^       0         ---   ---      ---            ---        ---
  Trial 5          0^a^                                0                                                                        ---   ---                     ---      ---      −110.793   33.894    90    −3.269   0.002^*∗∗*^    −178.131   −43.456
  Trial 1 × time   0.456                               0.03                                                                     90    14.885   0.049          0.395    0.516    277.036    47.934    90    5.780    0.006          181.806    372.266
  Trial 2 × time   −0.007                              0.03                                                                     90    −0.245   0.009^*∗*^     −0.068   0.053    −22.531    47.934    90    −0.470   0.050          −117.76    72.698
  Trial 3 × time   −0.031                              0.03                                                                     90    −1.03    0.007^*∗∗*^    −0.092   0.029    −23.058    47.934    90    −0.481   0.041          −118.288   72.17
  Trial 4 × time   −0.0242                             0.03                                                                     90    −0.793   0.004^*∗*^     −0.085   0.036    −25.565    47.934    90    −0.533   0.031          −120.795   69.664
  Trial 5 × time   0^a^                                0                                                                        ---   ---      0.001          ---      ---      0^a^       0         ---   ---      0.010          ---        ---

SE : Standard error; df: degrees of freedom; *t*: the student *t*-statistic; Sig.: the *p* value (associated with the correlation); LB : Lower bound. UB : Upper bound; Trial 1: negative control; Trial 2 : 1 × MIC. Trial 3 : 2 × MIC; Trial 4 : 4 × MIC and Trial 5 : 8 × MIC; ^*∗*^*p* \< 0.05; ^*∗*^*p* \< 0.01; ^*∗∗∗*^*p* \< 0.001, ^a^This parameter is set to zero because it is redundant; ^b^Dependent variable: CFU.

###### 

Estimates of covariance parameters in *S. aureus* ATCC 6538 and *S. enterica* ATCC 14028 behavior estimates of incubation time (A) and trial (B) fixed effect^a^.

                                    *Staphylococcus aureus* ATCC 6538   *Salmonella enterica* subsp. *enterica* serovar typhimurium ATCC 14028                                                                                                   
  --------------------------------- ----------------------------------- ------------------------------------------------------------------------ ---------- ------- ------- ---------- ----------- ---------- ---------- ------- ------- ------- -------
  A trial fixed                     Residual                            5.379                                                                    0.982239   5.477   0.000   3.761580   7.694       1.788      0.326      5.477   0.000   1.25    2.557
  Time \[subject = id\] variance    0.000^a^                            0.000                                                                    0.000      0.015   ---     ---        0.000^a^    0.000      0.000      0.018   ---     ---     
                                                                                                                                                                                                                                                 
  B time fixed                      Residual                            0.278                                                                    0.082      3.354   0.001   0.155110   0.499       0.278      0.082955   3.354   0.001   0.155   0.499
  Trial \[subject = id\] variance   0.278^a^                            0.000                                                                    0.815      0.038   ---     ---        0.2780^a^   0.000000   0.000      0.029   ---     ---     

^a^Dependent variable: CFU.

[^1]: Academic Editor: Daniela Beghelli
